Indegene Ltd.

₹542.3

Indegene Ltd.

Add Alert
Add Watchlist

₹542.3

₹542.3

-10.9 (-1.97%) - 30 Aug 2025 04:26 PM

About Company

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner. It achieves this by combining over two decades of healthcare domain expertise and fit-for purpose technology. 

Market Cap. ₹ 13,023 Cr.
52 Week - High/Low ₹ 736/499
P/E Ratio 66.95
P/B Ratio 6.90
Enterprise Value ₹ 12,910 Cr.
ROE % 13.07
RSI Value 35.03
EMA 50 570.28
EMA 200 581.28
Market Cap. ₹ 13,023 Cr.
52 Week - High/Low ₹ 736/499
P/E Ratio 29.80
P/B Ratio 4.98
Enterprise Value ₹ 12,704 Cr.
ROE % 20.45
RSI Value 35.03
EMA 50 570.28
EMA 200 581.28

Valuation

Calculators

Peer Comparison

Industry - Business Support

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.